GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PCL Inc (XKRX:241820) » Definitions » Cyclically Adjusted Price-to-FCF

PCL (XKRX:241820) Cyclically Adjusted Price-to-FCF : (As of Jun. 07, 2025)


View and export this data going back to 2017. Start your Free Trial

What is PCL Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


PCL Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for PCL's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PCL Cyclically Adjusted Price-to-FCF Chart

PCL Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PCL Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PCL's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, PCL's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PCL's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PCL's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where PCL's Cyclically Adjusted Price-to-FCF falls into.


;
;

PCL Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

PCL's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, PCL's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-50.122/122.5900*122.5900
=-50.122

Current CPI (Mar. 2025) = 122.5900.

PCL Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201412 0.000 99.099 0.000
201509 0.000 100.111 0.000
201512 -53.914 100.220 -65.948
201603 -38.450 100.561 -46.873
201606 -26.082 100.791 -31.723
201609 -31.818 101.461 -38.444
201612 -48.706 101.561 -58.791
201703 -48.192 102.851 -57.441
201706 -43.058 102.611 -51.442
201709 -30.145 103.491 -35.708
201712 -42.663 102.991 -50.782
201803 -105.504 104.101 -124.242
201806 -38.739 104.130 -45.606
201809 -64.637 105.651 -75.001
201812 -58.226 104.351 -68.403
201903 -48.189 104.491 -56.536
201906 -45.622 104.881 -53.325
201909 -50.444 105.200 -58.782
201912 -64.493 105.121 -75.210
202003 -166.667 105.354 -193.933
202006 44.104 105.112 51.438
202009 -11.726 106.198 -13.536
202012 -25.516 105.765 -29.575
202103 -768.457 107.357 -877.493
202106 -251.483 107.579 -286.575
202109 282.514 108.759 318.441
202112 -0.911 109.676 -1.018
202203 -86.059 111.848 -94.324
202206 151.782 114.072 163.115
202209 -124.351 114.715 -132.887
202212 -51.261 115.179 -54.559
202303 -13.468 116.507 -14.171
202306 -72.681 117.182 -76.035
202309 -106.819 118.964 -110.075
202312 -52.005 118.837 -53.647
202403 -70.313 120.123 -71.757
202406 -32.223 120.007 -32.916
202409 -109.817 120.861 -111.388
202412 -62.533 121.135 -63.284
202503 -50.122 122.590 -50.122

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


PCL  (XKRX:241820) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


PCL Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of PCL's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


PCL Business Description

Traded in Other Exchanges
N/A
Address
Star Valley No. 701, 99, Digitalro, 9gi, Geumcheongu, Seoul, KOR, 08510
PCL Inc is engaged in the development of vitro diagnostics products by SG Cap technology used in immobilizing disease biomarkers. It offers blood testing kit, multiplex antigen detection kits, and ultra-low volume non-contact liquid handling.In addition, the company offers platform services, such as sol-gel spotting service that immobilizes the customer's requested material using the SolB reagent; and SG ID service, which provides customers with a molecule of interest immobilized in the SolB reagent and identified.

PCL Headlines

No Headlines